We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s historical developments have led the agency to where it is today — balancing between industry’s call for accelerated approval of new drugs and the public’s concerns with safety, facing growing criticism over its relationship with industry and fighting for Senate confirmation of its commissioner.